The $4.65 Million AZAG Settlement: What a Consumer Fraud Case Teaches Attorneys About Proving Patient Harm

Introduction

In April 2017, Arizona Attorney General Mark Brnovich announced that Theranos had agreed to a $4.65 million consent judgment to refund every Arizona resident — more than 175,000 people — who had purchased one of the company’s blood tests between 2013 and 2016. The state’s Consumer Fraud Act case didn’t rest on Theranos admitting wrongdoing; the company denied violating the law. It rested on documented patient harm: test results that were later voided or corrected, and a clinical record showing real people had been given real numbers to act on.

That’s the same standard I bring to every malpractice chart I review. A company — or a hospital, or a provider — doesn’t have to admit fault for the documentation to prove what happened. It just has to be read correctly.

Inside the AZAG Case

What the State Actually Proved

The Arizona Attorney General’s office didn’t need Theranos to concede anything. The settlement required Theranos to refund the full cost of every blood test sold in the state during the relevant period — regardless of whether the results were later voided or corrected — because the state’s case was built on the documented outcomes themselves: roughly one in ten results were “ultimately voided or corrected,” a fact Theranos’ own attorneys conceded in the consent decree.

Why Full Refunds, Regardless of Outcome

Rather than trying to prove harm test-by-test, the state secured refunds for the entire affected population — because the documentation showed the pattern was systemic, not isolated. That’s an important lesson for any attorney building a case around a pattern of harm: the strongest cases don’t rely on cherry-picked examples. They rely on documentation broad and consistent enough that the pattern speaks for itself.

Applying This to a Malpractice Case

Isolated Incident, or Documented Pattern?

Every malpractice case starts with one patient. But the surrounding chart — prior visits, related complaints from other providers, internal quality reports, or even prior incident documentation — can reveal whether what happened to your client was an isolated error or a documented pattern the defendant knew about and didn’t fix.

Let the Record Show the Outcome, Not Just the Intent

The AZAG settlement didn’t hinge on proving Theranos intended to harm patients — it hinged on the documented outcome: inaccurate results reaching real people who acted on them. Malpractice cases work the same way. A provider’s intent is often disputed and hard to prove. What actually happened to the patient, documented in the chart, usually is not.

Building the Record Before You Negotiate

The Theranos settlements — AZAG, CMS, and the various civil suits — all followed a similar arc: once the documented pattern was undeniable, resolution followed relatively quickly. A well-documented malpractice file, assembled early through a flat-rate forensic review, puts you in the same position: able to negotiate from a position of proof, not just allegation.

What a Flat-Rate Chart Review Looks For in a Pattern Case

  • Prior incident or complaint documentation connected to the same provider, facility, or device
  • Internal quality assurance notes, if discoverable, showing the issue was known before your client was harmed
  • Result-versus-outcome discrepancies — cases where a test, scan, or chart entry didn’t match what later happened to the patient
  • Volume and consistency — whether the pattern shows up across multiple records, not just your client’s file

Frequently Asked Questions

Do I need to prove intent to win a malpractice case? No. Most malpractice claims turn on whether the standard of care was breached and caused harm — not on proving the provider intended to cause it. Documentation of the outcome is often more decisive than arguments about intent.

How can a chart review help me find a “pattern,” not just my client’s individual case? A forensic review looks for internal inconsistencies and red flags within the available records that may point toward a broader pattern, which can then guide further discovery requests aimed at confirming it.

Why did Arizona secure full refunds instead of case-by-case restitution? Because the documented rate of voided or corrected results made the harm systemic rather than isolated — a pattern strong enough that individualized proof for each consumer wasn’t required to justify the remedy.

Is a flat-rate review useful even in a single-plaintiff case with no obvious “pattern”? Yes. Even single-plaintiff cases benefit from a page-by-page forensic review to find the specific documentation gaps or contradictions that prove your case — pattern or not.

Conclusion

The Arizona Attorney General didn’t need an admission of guilt to secure $4.65 million in consumer restitution — the documented outcomes did the work. Malpractice attorneys have the same opportunity in nearly every case: a chart that, read carefully and completely, proves what happened regardless of what the other side is willing to admit.

Disclaimer

This article is for general informational purposes only and does not constitute legal advice. Details of the Arizona Attorney General’s settlement with Theranos are drawn from public consent judgment records and contemporaneous news reporting (2017); legal standards and strategy discussed are general in nature and should be independently evaluated by counsel for any specific case.

Scroll to Top